Rivermark Medical


Rivermark Medical is dedicated to redefining benign prostatic hyperplasia (BPH) treatment through innovative solutions. Led by practicing urologist Adam Kadlec, the company creates clinically grounded medical devices aimed at improving patient care. Their flagship product, FloStent, is a minimally invasive device designed to restore urinary flow and preserve treatment options, currently in development and clinical trials.

Industries

health-care
hospital-650c
medical-device

Nr. of Employees

small (1-50)

Rivermark Medical

Milwaukee, Wisconsin, United States, North America


Products

Minimally invasive nitinol urethral implant system

A small implantable nitinol device and compatible delivery system designed to be placed via cystoscopy to relieve symptoms of benign prostatic hyperplasia while preserving future treatment options.


Services

Clinical study participation program

Enrollment of qualified patients into investigational device studies with study-related care provided and compensation for time and travel associated with scheduled study visits.

Physician training and proctoring for device procedures

Training and certification of urologists to perform the implant procedure, including proctoring of procedures within clinical studies or early commercial use.

Expertise Areas

  • Benign prostatic hyperplasia (BPH) device therapy
  • Clinical trial management for implantable urology devices
  • Office-based urological procedure workflows
  • Medical device design and engineering
  • Show More (2)

Key Technologies

  • Nitinol-based implantable devices
  • Cystoscopic delivery systems
  • Minimally invasive urological implant procedures
  • Randomized multicenter clinical trial methodologies
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.